Health research reaches most people as a single sentence: a drug produced this much benefit, a food is better or worse than thought, a habit rewires your brain. Underneath each is a study whose design decides how much the sentence is worth.

Five questions get you most of the way.

1. Was it in people?

A great many striking results come from mice, cell cultures or lab-grown tissue. Those studies are how research begins, and most findings that work in mice do not work in humans.

If a headline does not say, it is worth assuming the answer may not be people. Reports that quietly mention “mouse models” halfway down are describing something years from any clinical use.

2. How many, and for how long?

A study of 28 participants over four weeks and one of 340,000 over a decade are not the same kind of evidence, even if both are competently done.

Small, short studies are useful for establishing whether something is worth investigating. They are weak evidence for whether it works, and almost no evidence for whether it is safe over time.

3. Was there a comparison group?

This is the one that matters most, and the one most often missing from coverage.

Without a control group, you cannot tell whether an effect came from the treatment or from everything else — the placebo effect, the extra attention participants receive, or the simple fact that people who volunteer for health studies tend to change other habits at the same time.

The strongest design randomly assigns participants to treatment or control and, where possible, keeps both participants and researchers unaware of who got which. That is not always possible, but its absence should lower your confidence.

4. Does it show correlation or cause?

Studies that follow large groups over years can reveal that people who do X are more likely to experience Y. That is genuinely valuable and it does not establish that X causes Y.

People who do X may differ in other ways — wealth, education, existing health, access to care — and researchers adjust for the factors they can measure, which is never all of them.

Careful papers say “associated with”. Coverage often converts that into “causes” somewhere between the journal and the headline.

5. How big is the effect, really?

A 50% increase in risk sounds alarming. If the underlying risk was two in ten thousand, the increase is one additional case per ten thousand people.

Relative figures make small effects sound dramatic; absolute figures tell you what it means for a person. Both are honest, and the choice of which to report is itself a decision.

The same applies to statistical significance, which indicates a result probably isn’t chance — not that it is large enough to matter.

Two things worth checking

Who funded it, which does not invalidate a study but belongs in your assessment. And whether it has been peer-reviewed and published, or announced by press release — conference abstracts and company statements are frequently reported as though they were published papers.

None of this requires scientific training. It requires reading the middle of the article rather than the top, which is where researchers put their own caveats and where they almost always survive intact.

---

General guidance on interpreting health research. For questions about your own health, speak to a qualified healthcare professional.